UroGen Pharma Ltd. (URGN)

40.90 -0.45 (-1.09%) USD  |  NASDAQ  |  Sep 28, 16:00
40.90 0.00 (0.00%) After-Hours: 18:11
More

UroGen Pharma Cash from Operations (Annual) : -162.44M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for URGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -162.44M
December 31, 2024 -96.77M
December 31, 2023 -76.38M
December 31, 2022 -87.56M
December 31, 2021 -84.89M
December 31, 2020 -105.89M
Date Value
December 31, 2019 -71.02M
December 31, 2018 -37.33M
December 31, 2017 -9.571M
December 31, 2016 4.189M
December 31, 2015 -7.175M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Xencor, Inc. -135.12M
MeiraGTx Holdings Plc -46.36M
Insmed, Inc. -935.01M
Ironwood Pharmaceuticals, Inc. 127.04M
Viking Therapeutics, Inc. -278.68M